Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Total 13F shares
-
8,785,097
-
Share change
-
+60,495
-
Total reported value
-
$67,961,804
-
Price per share
-
$7.32
-
Number of holders
-
48
-
Value change
-
+$530,664
-
Number of buys
-
21
-
Number of sells
-
20
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q1 2021
As of 31 Mar 2021,
Eton Pharmaceuticals, Inc. - Common Stock (ETON) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,785,097 shares.
The largest 10 holders included
Opaleye Management Inc., BlackRock Inc., AWM Investment Company, Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Sio Capital Management, LLC, TWO SIGMA INVESTMENTS, LP, and Westside Investment Management, Inc..
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.